[Form 4] FACTSET RESEARCH SYSTEMS INC Insider Trading Activity
Rhea-AI Filing Summary
Sanoke Viswanathan, who is listed as Chief Executive Officer and a director of FactSet Research Systems Inc. (FDS), reported insider acquisitions on 09/22/2025. He acquired 58,332 shares of common stock (reported as restricted stock units) at a $0 price, bringing his direct beneficial ownership to 58,332 shares. He also received an award of 297,902 employee stock options with an exercise price of $295.63 per share. The options include performance and vesting conditions: they vest only if, during the performance period ending on the fifth anniversary of the grant date, the 30‑day trailing VWAP equals or exceeds 150% of the grant‑date 30‑day VWAP, and they are not exercisable prior to the third anniversary of the grant date. The restricted stock units vest 25% annually and fully vest after four years.
Positive
- None.
Negative
- None.
Insights
TL;DR: CEO received sizable equity awards tying compensation to long‑term stock performance and tenure, aligning incentives with shareholders.
The reported grants combine time‑based restricted stock units and performance‑contingent options. The RSUs vest 25% annually and fully vest after four years, providing retention incentives. The options require a substantial 50% share‑price improvement (150% of grant VWAP over a multi‑year performance period) and include a minimum three‑year lock before exercise, indicating strong performance alignment and downside protection against near‑term option exercise. For governance oversight, key details are clear: number of shares/options, exercise price of $295.63, and explicit vesting/performance conditions. These terms are material to executive pay structure and dilution modelling for shareholders.
TL;DR: The awards are sizable and highly conditional, reducing immediate dilution but creating potential long‑term dilution if performance targets are met.
The option grant of 297,902 shares at $295.63 could represent material future dilution if the performance hurdle is achieved; however, the hurdle (150% of grant VWAP) and the minimum three‑year hold reduce near‑term dilution risk. The RSU grant of 58,332 shares vests over four years, producing predictable, time‑based dilution. From a risk perspective, these instruments incentivize stock performance but also concentrate CEO pay in equity, which may increase pay‑for‑performance alignment while exposing the CEO to share‑price volatility.